¨
P. Garner, H. U. Kaniskan / Tetrahedron Letters 46 (2005) 5181–5185
5185
4. Reviews of azomethine ylide cycloaddition chemistry: (a)
Grigg, R.; Sridharan, V. In Advances in Cycloaddition;
Curran, D. P., Ed.; JAI Press: Greenwich CT, 1993; Vol.
3, pp 161–204; (b) Kanemasa, S.; Tsuge, O. In Advances in
Cycloaddition; Curran, D. P., Ed.; JAI Press: Greenwich
CT, 1993; Vol. 3, pp 99–159; (c) Kanemasa, S. Synlett
2002, 1371; (d) Pearson, W. H.; Stoy, P. Synlett 2003,
903.
5. Myers, A. G.; Kung, D. W. J. Am. Chem. Soc. 1999, 121,
10828.
6. Grigg, R.; Thornton-Pett, M.; Xu, J.; Xu, L.-H. Tetra-
hedron 1999, 55, 13841.
7. Alcaide, B.; Almendros, P.; Alonso, J. M.; Aly, M. F.
J. Org. Chem. 2001, 66, 1351.
Scheme 5. One-pot intramolecular cascade [3+2] cycloaddition of
amino malonate derived azomethine ylide.
8. Cheng, Q.; Zhang, W.; Tagami, Y.; Oritani, T. J. Chem.
Soc., Perkin Trans. 1 2001, 452.
9. Chiacchio, U.; Antonino, C.; Rescinfina, A.; Bkaithan,
M.; Grassi, G.; Piperno, A.; Privitera; Romeo, G. Tetra-
hedron 2001, 57, 3425.
10. Dondas, H. A.; Fishwick, C. W. G.; Grigg, R.; Kilner, C.
Tetrahedron 2004, 60, 3473.
reaction conditions. The intramolecular [3+2] cycloaddi-
tion forms the basis for a new synthetic approach to the
bioxalomycin family of antibiotics.
11. Blaney, P.; Grigg, R.; Rankovic, Z.; Thornton-Pett, M.;
Xu, J. Tetrahedron 2002, 58, 1719.
Acknowledgment
12. Additions to analogous nitrones suggested that the anti-
selectivity should have been obtained with this substrate.
See: Merino, P.; Franco, S.; Merchan, F. L.; Tejero, T.
J. Org. Chem. 1998, 63, 5627.
Acknowledgment is made to the donors of the American
Chemical Society Petroleum Research Fund for support
of this research.
13. Seebach, D.; Prelog, V. Angew. Chem., Int. Ed. Engl. 1982,
21, 654.
Supplementary data
14. Garner, P.; Park, J. M. Org. Synth. 1991, 70, 18, The
D-serinal derivative was actually used for these experi-
ments. However, since we were only concerned with
diastereoselectivity in these model studies, the reaction is
depicted as if the L-antipode were used to facilitate
stereochemical comparisons with the natural product.
15. Hanessian, S.; Bayrakdarian, M. Tetrahedron Lett. 2002,
43, 9441. Also, see Ref. 12.
Supplementary data associated with this article can be
05.119. General experimental procedures and characteri-
zation for all new compounds are provided.
16. Chen, C.; Li, X.; Schreiber, S. L. J. Am. Chem. Soc. 2003,
125, 10174.
References and notes
17. Calculated LUMO energies for methyl acrylate and
acrylamide are ꢀ1.900 eV and ꢀ1.403 eV, respectively.
See: Zhan, C.-G.; Nichols, J. A.; Dixon, D. A. J. Phys.
Chem. A 2003, 107, 4184.
18. Groundwater, P. W.; Sharif, T.; Arany, A.; Hibbs, D. E.;
Hursthause, M. B.; Garnett, I.; Nyerges, M. J. Chem.
Soc., Perkin Trans. 1 1998, 2837.
19. (a) Joucla, M.; Hamelin, J. Tetrahedron Lett. 1978,
2885; (b) Amornraksa, K.; Grigg, R. Tetrahedron Lett.
1980, 21, 2197; (c) Husinec, S.; Savic, V.; Porter, A. E. A.
Tetrahedron Lett. 1988, 29, 6649; (d) Blazey, C. M.;
Heathcock, C. H. J. Org. Chem. 2002, 67, 298.
1. Zaccardi, J.; Alluri, M.; Ashcroft, J.; Bernan, V.; Kors-
halla, J. D.; Morton, G. O.; Siegel, M.; Tsao, R.; Williams,
D. R.; Maiese, W.; Ellestad, G. A. J. Org. Chem. 1994, 59,
4045.
2. For a comprehensive review of the bioxalomycins and
related tetrahydroisoquinoline antibiotics, see: Scott, J.
D.; Williams, R. M. Chem. Rev. 2002, 102, 166.
3. For an earlier, alternative 1,3-dipolar cycloadditive
approach, see: Garner, P.; Cox, P. B.; Anderson, J. T.;
Protasiewicz, J.; Zaniewski, R. J. Org. Chem. 1997, 62,
493.